Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-04

Clinical Trial Update: Triple vs High Dose Inhaled CORticosteroids [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating triple-dose versus high-dose inhaled corticosteroids for asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Galaxia Empírica | Conditions: Asthma | Phase 4 | Status: WITHDRAWN